Back to search

Article

RAG-17: A Novel siRNA Conjugate Demonstrating Efficacy in Late-Stage Treatment of SOD1 <sup>G93A</sup> ALS mice

2023-11-23

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by rapid progression and high mortality. With genetic mutations, particularly in the SOD1 gene, playing a significant role in ALS pathogenesis, targeted therapies have become a primary focus. This study introduces RD-12500 (RAG-17), a novel siRNA-ACO (Accessory Oligonucleotide) conjugate designed to address the challenges...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
12e8f1a6-24d8-504a-a437-fb759959d21b
DOI
10.1101/2023.11.23.568255
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RAG-17: A Novel siRNA Conjugate Demonstrating Efficacy in Late-Stage Treatment of SOD1 <sup>G93A</sup> ALS miceDOI 10.1101/2023.11.23.568255
Select a neighboring publication to make it the new centre.